European Parliament advances the discussion on the International Procurement Instrument (IPI)
Posted on 09.09.2021
In the first meeting after the summer recess, Members of the European Parliament Committees on International Trade (INTA) and Internal Market (IMCO) have discussed on 01 September the draft reports on the International Procurement Instrument (IPI).
The IPI was originally proposed by the Commission in 2012 to promote a level playing field and reciprocity in accessing third countries’ public procurement markets. The Commission’s proposal has gone through several revisions and following the Council’s agreement (June 2021) on a mandate for the negotiations with the European Parliament, the EP is now updating its position in the form of a new legislative report. The deadline for amendments in the two Committee is 09 September (IMCO) and 08 October (INTA).
MedTech Europe’s International Affairs team is closely monitoring the development of the IPI tool. Once adopted, IPI would be a relevant instrument for the medtech industry as European companies are confronted with challenging access to the procurement markets in third countries due to lack of transparency and local content requirements in public tenders.
For more information, please contact Dario Belluomini, Manager International Affairs.